(1)
Pękala, A.; Aebisher, D.; Pardak, P.; Filip, R. Efficacy and Safety of Biosimilar IFX (CT-P13) and Adalimumab in Patients With Active Fistulizing Perianal Crohn’s Disease naďve to Anti-TNF Therapy: Preliminary Results from the POLIBD Study. Eur J Clin Exp Med 2019, 17, 12–15.